| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Iron (III) isomaltoside 1000 |
| Brand | Monover® |
| Indication | For the treatment of Iron deficiency anaemia when oral iron preparations are ineffective or cannot be used or where there is a clinical need to deliver iron rapidly. |
| Assessment Process | |
| Rapid review commissioned | 10/10/2015 |
| Rapid review completed | 18/11/2015 |
| Rapid review outcome | Full Pharmacoeconomic Assessment Not Recommended |